Assessing Symptom Burden in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Patients

Area of Science:

• Hematology
• Oncology
• Neoplastic Syndromes

Background:

• Myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes are rare chronic myeloid neoplasms.
• These syndromes share clinical features, mutations, and disease progression with other chronic myeloid malignancies.
• Existing data indicates patients often experience persistent, poorly managed symptoms, potentially leading to underdiagnosis.

Purpose of the Study:

• To explore the origins of symptoms in patients diagnosed with MDS/MPN overlap syndromes.
• To review current tools for assessing symptom burden in this patient population.
• To highlight the importance of symptom management and quality of life in MDS/MPN overlap syndromes.

Main Methods:

• Literature review of existing studies on MDS/MPN overlap syndromes.
• Analysis of symptom etiologies and their impact on patients.
• Evaluation of current symptom burden assessment tools.

Main Results:

• Symptom burden in MDS/MPN overlap syndromes is significant and may be underrecognized.
• A variety of factors contribute to the symptom complex experienced by these patients.
• Available assessment tools provide a framework for evaluating symptom burden.

Conclusions:

• Symptom burden is a critical factor in managing MDS/MPN overlap syndromes.
• Ongoing research aims to further elucidate symptom burden and its impact on quality of life.
• Improved understanding and management of symptoms are essential for patient care.